ES414411A1 - Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano. - Google Patents

Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.

Info

Publication number
ES414411A1
ES414411A1 ES0414411A ES414411A ES414411A1 ES 414411 A1 ES414411 A1 ES 414411A1 ES 0414411 A ES0414411 A ES 0414411A ES 414411 A ES414411 A ES 414411A ES 414411 A1 ES414411 A1 ES 414411A1
Authority
ES
Spain
Prior art keywords
steroids
translation
procedure
preparation
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0414411A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES414411A1 publication Critical patent/ES414411A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
ES0414411A 1972-05-05 1973-05-04 Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano. Expired ES414411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
ES414411A1 true ES414411A1 (es) 1976-02-01

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0414411A Expired ES414411A1 (es) 1972-05-05 1973-05-04 Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.

Country Status (16)

Country Link
JP (1) JPS4961150A (de)
AT (1) AT355232B (de)
AU (1) AU475168B2 (de)
BE (1) BE799102A (de)
CA (1) CA1013341A (de)
CH (1) CH617710A5 (de)
DE (1) DE2322532A1 (de)
ES (1) ES414411A1 (de)
FR (1) FR2183792B1 (de)
GB (1) GB1430942A (de)
IE (1) IE37596B1 (de)
IL (1) IL42196A (de)
LU (1) LU67546A1 (de)
NL (1) NL7306234A (de)
SE (1) SE400771B (de)
ZA (1) ZA733035B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
KR100338287B1 (ko) * 1994-02-14 2002-11-30 푸르듀 파머 리미티드 감마-아미노부티르산a수용체의알로오스테리조절용안드로스탄및프레그난
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
CN119192266A (zh) 2011-10-14 2024-12-27 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
MX2015002252A (es) 2012-08-21 2015-07-21 Sage Therapeutics Inc Metodos para tratar epilepsia o estado de epilepsia.
JP6470258B2 (ja) 2013-04-17 2019-02-13 セージ セラピューティクス, インコーポレイテッド 19−ノルc3,3−ジ置換c21−n−ピラゾリルステロイドおよびその使用方法
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ES2848823T3 (es) 2013-08-23 2021-08-12 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
ME03809B (de) 2014-10-16 2021-04-20 Sage Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von störungen des zentralen nervensystems
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP4155314A1 (de) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroaktive steroide, zusammensetzungen und verwendungen davon
HK1258616A1 (zh) 2016-03-08 2019-11-15 Sage Therapeutics, Inc. 神经活性类固醇、组合物、及其用途
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
CA1013341A (en) 1977-07-05
SE400771B (sv) 1978-04-10
IL42196A0 (en) 1973-07-30
CH617710A5 (en) 1980-06-13
FR2183792A1 (de) 1973-12-21
LU67546A1 (de) 1973-07-13
JPS4961150A (de) 1974-06-13
DE2322532A1 (de) 1973-11-22
GB1430942A (en) 1976-04-07
AT355232B (de) 1980-02-25
ATA395173A (de) 1979-07-15
NL7306234A (de) 1973-11-07
BE799102A (fr) 1973-11-05
FR2183792B1 (de) 1977-07-15
IL42196A (en) 1978-10-31
AU475168B2 (en) 1976-08-12
IE37596L (en) 1973-11-05
ZA733035B (en) 1974-04-24
AU5528473A (en) 1974-11-07
IE37596B1 (en) 1977-08-31

Similar Documents

Publication Publication Date Title
ES414411A1 (es) Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.
ES421253A1 (es) Un procedimiento para la preparacion de nuevos 11,11-alco- hiliden-esteroides.
NL170420C (nl) Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat.
FR2314197A1 (fr) Procede de preparation d'oxo-20 steroides insatures en 9,11
DK139031B (da) Analogifremgangsmåde til fremstilling af i 21-stillingen alkylerede 3,20-dioxo-delta4-steroider af pregnanrækken.
ES439952A1 (es) Un procedimiento para la preparacion de d-homoesteroides de la serie del pregnano.
ES414508A1 (es) Procedimiento de fabricacion de un compuesto de accion hi- polipemiante.
BG33737A3 (bg) Метод за получаване на заместени в 17-та позиция стероиди от прегнановия ред
ES407142A1 (es) Procedimiento para la obtencion de n-(1-etil-alfa-pirroli- dilmetil) - 2 - metoxi - 5-sulfamidobenzamida.
ES412235A1 (es) Procedimiento para producir acetatos.
ES408509A1 (es) Un procedimiento para la preparacion de 3-alfa-hidroxi-19- nor-5-alfa-pregnado-11,20-diona.
ES319114A1 (es) Un procedimiento de preparacion de los 21-hidroxi esteroides de la serie del pregnano esterificados en la posicion 21.
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
ES429338A1 (es) Procedimiento para la preparacion del esteroide 21-acetato de 16-alfa,17-alfa-ciclopentilidendioxi-3,20-oliona
ES455933A1 (es) Procedimiento para la preparacion de nuevos esteroides.
ES444637A1 (es) Procedimiento de preparacion de derivados de esteroides.
ES444231A1 (es) Procedimiento para la preparacion de esteres del acido (1- bencil-1h-indazoil-3-il)-oxi)-acetico.
ES397035A1 (es) Un procedimiento para preparar un coprecipitado de un agen-te antiinflamatorio y un lignosulfato.
ES382098A1 (es) Procedimiento para la preparacion de nuevas 14 beta-hidro- xi-15 alfa-aciloxi-cardenolidas.
SE7601753L (sv) Sett att framstella 3-enoletrar av 11beta-hydroxi-delta?724-pregnen-3-oner och derivat derav
FI52100C (fi) Menetelmä uudien pregnaanisarjaan kuuluvien, tulehduksenvastaisten 21- asemassa alkyloitujen steroidien valmistamiseksi.
IE37597L (en) 21-fluoro pregnanes.
GB1008273A (de)
FR2108537A5 (en) 2-haloalkyl-5-phenyl-1,3,4-oxiadiazoles prepn - from haloalkanoic acids phenyl acid hydrazides and a mineral acid halide
NL176228C (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat met anti-inflammatoire werking, dat een jodofoor en een steroide bevat.